Buscar
Congreso SOLACI

Búsqueda de: foramen ovale

Si no está conforme con los resultados, inténtelo de nuevamente.
Other

Transcatheter Closure of Patent Foramen Ovale in Thrombophilia Patients

The transcatheter treatment of patent foramen ovale (PFO) has been shown to reduce thromboembolic events in patients...
solaci -
Ir
Institutional News

Bulletin 116 ProEducar | Percutaneous Closure of Patent Foramen Ovale

A new edition of the ProEducar Educational Bulletin has arrived for Fellows and interventionists in training. On...
solaci -
Ir
Other

Long-Term Foramen Ovale Closure after Cryptogenic Stroke

Patent foramen ovale closure is the standard treatment for cryptogenic stroke patients. However, there are is little...
solaci -
Ir
Other

Stroke, Migraine and Patent Foramen Ovale Not Necessarily Temporary Associated

Cryptogenic stroke patients with migraine have high prevalence (79%) of patent foramen ovale (PFO) with right to...
solaci -
Ir
Other

ACC 2018 | Echocardiographic Data Help Better Choose Patients for Patent Foramen Ovale Closure

A new randomized controlled trial of patients who underwent patent foramen ovale (PFO) closure in cryptogenic stroke...
solaci -
Ir
Other

Closure of Patent Foramen Ovale for the Treatment of Migraine

Migraine is one of the more frequent disabling disorders worldwide, but its physiopathology remains unclear. Since migraine is...
solaci -
Ir
Structural heart disease

Amplatzer and Figulla Devices Prove to Be Safe for Percutaneous Patent Foramen Ovale Closure

Courtesy of Dr. José Álvarez. In patients with presumed paradoxical embolism through a patent foramen ovale (PFO) who...
solaci -
Ir
Day 2

Cierre de CIA, foramen ovale permeable, persistencia del ductus arterioso: Indicaciones y resultados.

Amalio Benítez2011-05-13
solaci -
Ir

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad